Clinical Drug Experience Knowledgebase

Amyotrophic Lateral Sclerosis (Phase 1)

Angina Pectoris (Phase 1)

Arthritis, Rheumatoid (Phase 1)

Asthma (Phase 1)

Autistic Disorder (Phase 1)

Brain Injuries, Traumatic (Phase 1)

Cerebral Palsy (Phase 1)

Cystitis, Interstitial (Phase 1)

Diabetes Mellitus (Phase 1)

Diabetic Retinopathy (Phase 1)

Erectile Dysfunction (Phase 1)

Eye Diseases (Phase 1)

Frailty (Phase 1)

Glaucoma (Phase 1)

Heart Failure (Phase 1)

Idiopathic Pulmonary Fibrosis (Phase 1)

Inflammatory Bowel Diseases (Phase 1)

Intellectual Disability (Phase 2)

Lung Diseases (Phase 1)

Lupus Erythematosus, Systemic (Phase 1)

Macular Degeneration (Phase 1)

Multiple Sclerosis (Phase 1)

Oligospermia (Phase 1)

Optic Atrophy (Phase 1)

Optic Nerve Injuries (Phase 1)

Osteoarthritis (Phase 1)

Osteoporosis (Phase 1)

Ovarian Diseases (Phase 1)

Parkinson Disease (Phase 1)

Penile Induration (Phase 1)

Peripheral Nervous System Diseases (Phase 1)

Pulmonary Disease, Chronic Obstructive (Phase 1)

Renal Insufficiency, Chronic (Phase 1)

Retinitis Pigmentosa (Phase 1)

Scleroderma, Systemic (Phase 1)

Skin Ulcer (Phase 1)

Spinal Cord Injuries (Phase 1)

Spondylarthritis (Phase 1)

Stroke (Phase 1)

Testicular Diseases (Phase 1)

Tourette Syndrome (Phase 1)

Trigeminal Neuralgia (Phase 1)